Aegerion Pharmaceuticals, Inc.

MA · United States · Reporting entity ID 100000000128

Total reported 2019–2025

$8.03M

#563 of 2,960 reporting companies — 0% of all reported industry payments

$7.87M in general payments across 622 records, plus $160K in research funding across 103 records.

How it breaks down

General payments $7,868,596

Research funding $159,503

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.